Trial Profile
Investigation of Safety, Tolerability and Bioavailability of NN9925 in Healthy Male Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Mar 2017
Price :
$35
*
At a glance
- Drugs NN 9925 (Primary) ; NN 9925 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 29 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Aug 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 24 Mar 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.